glp 1 and thyroid cancer GLP-1 Receptor Agonists Risk, Rodent Data and FDA Warning, • In rodents, GLP-1 receptor agonists (GLP-1 RAs) stimulate thyroid C-cells, increasing the incidence of medullary thyroid GLP-1 Thyroid Cancer Human Data:

doi: 10.1093/hmg/ddu542

115 Dihydroartemisinin can significantly inhibit the viability of leukemia cells by accelerating ferritin degradation, 136 and increase the cytotoxicity of cisplatin to PDAC cells

Pharmacol Res (2021) 165:105465

1 Some have cited concern over confounding variables including the fact that patients with diabetes are at an increased risk of acute pancreatitis regardless of treatment choice

Cardiolipins and mitochondrial proton-selective leakage

More broadly, they emphasise a significant limitation of antioxidant-based strategies: addressing redox imbalance with a single agent does not invariably result in clinically significant symptom relief